APLM Apollomics, Inc.
Healthcare$14.09-1.56%ClosedMarket Cap: $15.5M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
-1.86
P/S
1.83
EV/EBITDA
-1.36
DCF Value
$-581.83
FCF Yield
-82.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
-111.4%
Net Margin
-128.7%
ROE
288.4%
ROA
-162.9%
ROIC
-1586.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $0.00 | NaN% | $1.1M | $1.6M | $— | — |
| FY null | $8.5M | 0.0% | $-9.5M | $-10.9M | $— | — |
| Q2 null | $8.5M | 0.0% | $-10.6M | $-12.5M | $— | — |
| Q4 null | $-1.6M | 100.0% | $-16.8M | $-18.7M | $— | — |
| FY null | $198.0K | 100.0% | $-42.1M | $-53.9M | $— | — |
| Q2 null | $1.8M | 100.0% | $-25.3M | $-35.2M | $— | — |
| Q4 null | $333.0K | 100.0% | $-28.3M | $-21.9M | $— | — |
| FY null | $821.0K | 100.0% | $-54.0M | $-172.6M | $— | — |
| Q2 null | $488.0K | 100.0% | $-25.7M | $-150.7M | $— | — |
| Q4 null | $-272.0K | 100.0% | $-22.6M | $-237.4M | $— | — |
| FY null | $323.0K | 100.0% | $-45.1M | $-240.8M | $— | — |
| Q2 null | $595.0K | 100.0% | $-22.5M | $-3.4M | $— | — |